CLEVELAND, Feb. 14, 2022 — The Louise H. and David S. Ingalls Foundation has renewed support of Eversight’s mission by awarding a $75,000 grant to support four critical research studies at the Eversight Center for Vision and Eye Banking Research in Cleveland.
The Ingalls Foundation and Eversight share a rich history and mission alignment. Foundation founder David S. Ingalls, Sr. was a champion of eye banking who provided the vision, leadership and financial means to create the Central Eye Bank for Sight Restoration, which later became the Cleveland Eye Bank. In 2015, the Cleveland Eye Bank joined a network of eye banks across the U.S. to form what is now known as Eversight.
The Louise H. and David S. Ingalls Foundation is dedicated to the improvement of the physical, educational, mental and moral condition of humanity, primarily in the Cleveland area. Their gift will allow Eversight to advance four ongoing vision and eye banking research projects. The four studies this gift supports aim to have the following impact.
- Discover strategies to mitigate the risk of COVID-19 transmission to corneal recipients.
- Reduce visual impairment in individuals suffering from mucopolysaccharidosis disorders.
- Utilize SNO therapy to fortify corneal storage media to improve and extend the storage duration of corneas.
- Develop a novel composite biomaterial (CorGel) to overcome the surgical challenges associated with common corneal transplant procedures.
Each of these studies has the potential to impact thousands of individuals living worldwide with visual impairment.
“Eversight is thrilled to continue our partnership with The Louise H. and David S. Ingalls Foundation,” said Teresa Clark, Vice President of Philanthropy, Eversight. “We sincerely appreciate the Foundation’s longstanding support for Eversight’s mission to restore sight and prevent blindness through the healing power of donation, transplantation and research.”
Eversight is a nonprofit organization with a mission to restore sight and prevent blindness through the healing power of donation, transplantation and research. The Eversight network is responsible for recovering, evaluating and providing human eye tissue for transplantation; supporting research into the causes and cures of blinding eye conditions; promoting donation awareness through public and professional education; and providing humanitarian aid to people around the world in need of corneal transplantation. Operating in Connecticut, Illinois, Michigan, New Jersey, Ohio and South Korea, Eversight works in collaboration with surgeons, researchers, academic medical centers and eye banks across the United States and abroad. For more information, visit eversightvision.org.